1. Home
  2. NAMS vs GNL Comparison

NAMS vs GNL Comparison

Compare NAMS & GNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMS
  • GNL
  • Stock Information
  • Founded
  • NAMS 2019
  • GNL 2011
  • Country
  • NAMS Netherlands
  • GNL United States
  • Employees
  • NAMS N/A
  • GNL N/A
  • Industry
  • NAMS Biotechnology: Pharmaceutical Preparations
  • GNL Real Estate Investment Trusts
  • Sector
  • NAMS Health Care
  • GNL Real Estate
  • Exchange
  • NAMS Nasdaq
  • GNL Nasdaq
  • Market Cap
  • NAMS 1.7B
  • GNL 1.6B
  • IPO Year
  • NAMS N/A
  • GNL N/A
  • Fundamental
  • Price
  • NAMS $25.50
  • GNL $7.18
  • Analyst Decision
  • NAMS Strong Buy
  • GNL Buy
  • Analyst Count
  • NAMS 6
  • GNL 5
  • Target Price
  • NAMS $36.20
  • GNL $9.50
  • AVG Volume (30 Days)
  • NAMS 1.4M
  • GNL 1.6M
  • Earning Date
  • NAMS 02-06-2025
  • GNL 11-06-2024
  • Dividend Yield
  • NAMS N/A
  • GNL 15.38%
  • EPS Growth
  • NAMS N/A
  • GNL N/A
  • EPS
  • NAMS N/A
  • GNL N/A
  • Revenue
  • NAMS $33,594,000.00
  • GNL $812,621,000.00
  • Revenue This Year
  • NAMS $129.49
  • GNL N/A
  • Revenue Next Year
  • NAMS N/A
  • GNL N/A
  • P/E Ratio
  • NAMS N/A
  • GNL N/A
  • Revenue Growth
  • NAMS 78.77
  • GNL 102.00
  • 52 Week Low
  • NAMS $10.50
  • GNL $6.52
  • 52 Week High
  • NAMS $27.29
  • GNL $10.19
  • Technical
  • Relative Strength Index (RSI)
  • NAMS 62.30
  • GNL 40.83
  • Support Level
  • NAMS $24.40
  • GNL $7.00
  • Resistance Level
  • NAMS $26.95
  • GNL $7.42
  • Average True Range (ATR)
  • NAMS 1.66
  • GNL 0.18
  • MACD
  • NAMS 0.41
  • GNL 0.01
  • Stochastic Oscillator
  • NAMS 81.51
  • GNL 27.38

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About GNL Global Net Lease Inc.

Global Net Lease Inc is a real estate investment trust that manages a globally diversified portfolio of commercial real estate properties. The company is engaged in the ownership, management, operating, lease, acquisition, investment, and sale of the portfolio assets. Its segments include Industrial & Distribution; Multi-Tenant Retail; Single-Tenant Retail ; and office. The company derives maximum revenue from industrial and distribution segment. The company geographically operates in Unites States, United Kingdom, Canada and Europe.

Share on Social Networks: